Synergistic effects of chemotherapeutic drugs in lymphoma cells are associated with down-regulation of inhibitor of apoptosis proteins (IAPs), prostate-apoptosis-response-gene 4 (Par-4), death-associated protein (Daxx) and with enforced caspase activation

This publication has 35 references indexed in Scilit:

• Mitochondrial control of cell death
  Nature Medicine, 2000
• In vitro cytotoxic effects of fludarabine (2-F-ara-A) in combination with commonly used antileukemic agents by isobologram analysis
  Leukemia, 2000
• Induction of Apoptosis by 2-Chloro-2'deoxyadenosine (2-CdA) Alone and In Combination with other Cytotoxic Drugs: Synergistic Effects on Normal and Neoplastic Lymphocytes by Addition of Doxorubicin and Mitoxantrone
  Leukemia & Lymphoma, 2000
• Functional CD95 ligand and CD95 death-inducing signaling complex in activation-induced cell death and doxorubicin-induced apoptosis in leukemic T cells
  Blood, 2000
• In Vitro Evaluation of Fludarabine in Combination With Cyclophosphamide and/or Mitoxantrone in B-Cell Chronic Lymphocytic Leukemia
  Blood, 1999
• Activation of Apoptosis Pathways by Anticancer Drugs
  Published by Springer Nature ,1999
• The central executioners of apoptosis: caspases or mitochondria?
  Trends in Cell Biology, 1998
• Mitochondria and Apoptosis
  Science, 1998
• Bcl-2 family proteins and mitochondria
  Biochimica et Biophysica Acta (BBA) - Bioenergetics, 1998
• Involvement of the CD95 (APO–1/Fas) receptor/ligand system in drug–induced apoptosis in leukemia cells
  Nature Medicine, 1996